Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions

por de Wilt, J H W, Manusama, E R, van Etten, B, van Tiel, S T, Jorna, A S, Seynhaeve, A L B, ten Hagen, T L M
Publicado 2000

The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

por Abou El Hassan, M A I, Verheul, H M W, Jorna, A S, Schalkwijk, C, van Bezu, J, van der Vijgh, W J F, Bast, A
Publicado 2003